EliseAI
- HealthTech
- New York City, New Work, United States
Company Overview
EliseAI is an AI company founded in 2017 that builds software to automate complex operational workflows in housing and healthcare. Its platform helps property managers handle leasing, maintenance, resident communications, renewals, and other stages of the rental journey. In healthcare, EliseAI automates administrative workflows including patient communications, scheduling, intake, referrals, and related tasks.
The company combines conversational AI, machine learning, and agentic AI with deep integrations into industry workflows. EliseAI says its technology now supports one in six U.S. apartments and that the company surpassed $200 million in annual recurring revenue in 2026. Headquartered in New York, the company also operates offices in San Francisco, Boston, Chicago, and Toronto.
QueryFeedz Insight
EliseAI illustrates how vertical AI is moving beyond general-purpose assistants into complex, industry-specific operations. The company started with housing and expanded into healthcare, embedding AI into workflows where compliance, integrations, and domain-specific processes matter. Its latest $350 million financing values the company at $4 billion, while EliseAI says it has surpassed $200 million in ARR. The launch of Apollo also points toward a broader shift from AI tools toward AI agents that can execute work across existing business systems.
Funding & Investors
- Latest funding
- $350
- Latest round
- Pre-Seed
- Latest funding date
- September 2026
Investors
- Andreessen Horowitz (a16z), Bessemer Venture Partners, Ontario Teachers' Pension Plan, Sapphire Ventures, and Navitas Capital.
Founders
- Minna Song — Co-Founder & CEO
- Tony Stoyanov — Co-Founder & CTO
Company Links
Ataraxis AI Visit Ataraxis AI website (opens in a new tab)
Artificial Intelligence
Ataraxis AI is a clinical AI startup using digital pathology and multimodal foundation models to personalize cancer prognosis and treatment selection. Its Ataraxis Breast platform aims to help oncologists estimate recurrence risk and predict individual treatment response.
Tennr Visit Tennr website (opens in a new tab)
HealthTech
Tennr is a healthcare AI company building an agentic patient orchestration platform that automates documentation, referrals, insurance workflows, and patient communications.
NewLimit Visit NewLimit website (opens in a new tab)
Artificial Intelligence
NewLimit is a biotechnology startup combining AI, genomics, and epigenetic reprogramming to develop medicines targeting age-related diseases and extending healthy human lifespan
Abridge Visit Abridge website (opens in a new tab)
Artificial Intelligence
Abridge develops healthcare AI that converts clinical conversations into structured documentation and supports clinical, financial, and evidence-based workflows.